CTOs on the Move

Centerlight Health System

www.centerlight.org

 
CenterLight Health System ranks among the nation`s leading resources for long-term residential and community-based health care. A voluntary, nonprofit organization, CenterLIght has made life better for tens of thousands of New Yorkers from all backgrounds and walks of life. It first opened its doors to the poor, chronically ill and disabled just after the First World War.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Gerardo Escalera
Director Information Technology/CIO Profile

Similar Companies

American Academy of Dental Group Practice

American Academy of Dental Group Practice is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bluegrass Family Health

Bluegrass Family Health, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Bluegrass Family Health, Inc. is based in Lexington, KY. You can find more information on Bluegrass Family Health, Inc. at www.bgfh.com

Apollo Health Street

Apollo Health Street is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.